SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 278 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $1,469,000 | -12.5% | 15,016 | +35.9% | 1.61% | +76.8% |
Q2 2019 | $1,679,000 | -28.3% | 11,050 | -23.8% | 0.91% | -58.0% |
Q3 2018 | $2,343,000 | +57.6% | 14,508 | +29.0% | 2.16% | +48.1% |
Q2 2018 | $1,487,000 | -31.1% | 11,249 | -61.4% | 1.46% | -45.8% |
Q1 2018 | $2,158,000 | -10.0% | 29,133 | -32.4% | 2.70% | -17.1% |
Q4 2017 | $2,399,000 | -49.7% | 43,125 | -59.0% | 3.26% | -41.1% |
Q3 2017 | $4,766,000 | -11.0% | 105,066 | -33.8% | 5.53% | -12.9% |
Q2 2017 | $5,353,000 | +107.4% | 158,810 | +82.2% | 6.35% | +76.4% |
Q1 2017 | $2,581,000 | – | 87,180 | – | 3.60% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
TOBAM | 371,107 | $27,659,000 | 1.18% |
Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |